TrialJapanese journal of clinical oncology2021

Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation study.

Toshihiro Kudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.